Researchers start a new clinical study of two potential Ebola treatments in eastern Democratic Republic of Congo amid a worsening outbreak, with reporting describing the trial as beginning in early July and formally getting under way on Thursday. Multiple outlets say the World Health Organization announces the enrollment of the first participant, signaling that the trial is moving from planning into active recruitment and treatment.
Accounts from the outbreak area, including coverage focused on Bunia in Ituri province, describe the launch at or near an Ebola treatment center as urgent and driven by the need to respond to continued transmission. The virus is identified as the Bundibugyo species of Ebola, which is described as less common than other Ebola-causing virus types.
While details of the two study treatments are not consistently provided across the sources, the overall reporting aligns on the purpose of the trial: to evaluate experimental options that could help treat people affected during the still-expanding outbreak. Residents in the epicentre express cautious hope as the study begins, following weeks of fear and community grief.
